Joshua Prince, MBA joined Vistagen in November 2021 bringing over two decades of experience in strategic insights and analytics supporting pharmaceutical development and commercialization through various roles responsible for market research, forecasting, analytics, business development, and competitive intelligence. His recent positions prior to joining Vistagen include leading Forecasting and Performance Analytics at CSL Behring, and at Teva Pharmaceuticals leading North America Commercial Insights and Analytics as well as Global CNS Insight. Earlier in his career he worked in a variety of foundational insight roles at AstraZeneca. Through his career Mr. Prince has developed extensive expertise supporting products from PHI development to launch and through late life-cycle management across multiple therapy areas. His extensive experience in Psychiatry and Central Nervous System is complemented with experience in Rare Disease, Diabetes, Pain, Cardiovascular, and Immunology. Mr. Prince holds a BS in Mechanical Engineering from the University of Missouri-Rolla, and an MBA from The Pennsylvania State University.